Wasn't High Tech Supposed to Usher in the New World Order?

Portfolio magazine has an article about Decode Genetics, which it refers to as a "high-tech victim of the new world economic order." The article notes Nasdaq's delisting warning to the company, adding that "this comes against a backdrop of biotech markets that are not only plummeting, but may be facing particularly hard times as investors pull back from an industry that even in bullish times requires massive amounts of capital and years of R&D before revenues come in." CEO Kari Stefansson has said that his team is "in the process of creating a smaller, leaner Decode."